Role of the gut microbiota in brain function under physiological conditions and in pathological states
Clinical nutrition and metabolism · 26.02.2026 · 7 (1) · 15-29
DOI: 10.17816/clinutr698835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical nutrition and metabolism, online erschienen am 26.02.2026. Verfasst von Irina A. Savvina und 3 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The gut microbiota is closely linked to the central nervous system through multilevel regulatory mechanisms; however, this relationship remains understudied in the context of sepsis-associated encephalopathy. AIM: This work aimed to compare metabolomic profiles of patients with sepsis-associated encephalopathy (SAE) and volunteers. METHODS: Plasma samples were collected from patients with SAE and from volunteers. The metabolomic profile of SAE was defined as the set of metabolites that differed remarkably between patients with SAE and controls. Blood samples were obtained on the day of sepsis diagnosis before initiation of intensive care and were centrifuged. Plasma aliquots were stored at −80 °C. Following sample preparation, metabolomic analysis of plasma samples was performed using high-performance liquid chromatography coupled with high-resolution mass spectrometry. Statistical analysis was conducted using Compass DataAnalysis, ProteoWizard MSConvert, and the MetaboAnalyst 5.0 platform. A two-sided Student t test and the Mann–Whitney test were applied. Fold changes in metabolite levels (log2FC) and standardized effect sizes (Cohen d) were calculated. Multiple testing correction was performed using the Benjamini–Hochberg method (FDR, q = 0.05). Dimensionality reduction and classification methods included principal component analysis, partial least squares discriminant analysis (PLS-DA), orthogonal projections to latent structures discriminant analysis (OPLS-DA), heatmap visualization, and random forest modeling. RESULTS: The main group included patients with SAE (n = 28; 20 men, 8 women; age 69 [58-74] years), and the control group consisted of volunteers without SAE (n = 27; 20 men, 7 women; age 70 [62-75] years). In the main group, mean scores within the first 24 hours were 9.5 for the SOFA and 44.5 for the SAPS II. The mean procalcitonin level was 43.9 ng/mL. The primary sources of infection were hospital-acquired pneumonia (n =16, 57%), secondary peritonitis (n = 7, 25%), infective endocarditis (n = 3, 11%), and urinary tract infections (n = 2, 7%). Hospital mortality in the main group was 60%. Between-group comparison revealed systemic differences in concentrations of microbiome-associated metabolites. Substantial alterations involved indole, phenolic, kynurenine, and bile acid metabolism, as well as key organic acids and neurotransmitters. CONCLUSIONS: The identified systemic metabolic differences between patients with SAE and controls indicate systemic and complex dysregulation of the microbiome–metabolome–brain axis, which may play a considerable role in the pathogenesis of this complication.
Zitieren
APA
Savvina, I. A., Kessenikh, E. D., Bykova, K. M., & Murashko, E. A. (2026). Role of the gut microbiota in brain function under physiological conditions and in pathological states. Clinical nutrition and metabolism, 7(1), 15-29. https://doi.org/10.17816/clinutr698835
Vancouver
Savvina IA, Kessenikh ED, Bykova KM, Murashko EA. Role of the gut microbiota in brain function under physiological conditions and in pathological states. Clinical nutrition and metabolism. 2026;7(1):15-29. doi:10.17816/clinutr698835
BibTeX
@article{Savvina2026,
author = {Savvina, Irina A. and Kessenikh, Elizaveta D. and Bykova, Kristina M. and Murashko, Ekaterina A.},
title = {Role of the gut microbiota in brain function under physiological conditions and in pathological states},
journal = {Clinical nutrition and metabolism},
year = {2026},
volume = {7},
number = {1},
pages = {15--29},
doi = {10.17816/clinutr698835}
}
EUVIMED